Effects of intrapallidal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system

Synapse

Volumn 28, Issue 1, 1998, Pages 27-32

  Sañudo Peña, M Clara ^a   Walker, J Michael ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Basal ganglia; Cannabinoids; Circling; Dopamine; Globus pallidus

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID; CANNABINOID RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; QUINPIROLE; BENZAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG RECEPTOR; SK&F 82958;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; GLOBUS PALLIDUS; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; DRUG ANTAGONISM; DRUG EFFECT; MOTOR ACTIVITY; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; DOPAMINE AGONISTS; GLOBUS PALLIDUS; MALE; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 85047680535     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199801)28:1<27::AID-SYN4>3.3.CO;2-8     Document Type: Article

References (39)

1. Aiko, Y., Hosokawa, S., Shima, F., Kato, M., and Kitamura, K. (1988) Alterations in local cerebral glucose utilization during electrical stimulation of the striatum and globus pallidus in rats. Br. Res., 442:43-52.
2. Albin, R.L., Young, A.B., and Penney, J.B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci., 12:366-375.
3. 2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Br. Res., 691:106-114.
4. Costall, B., Naylor, R.J., and Olley, J.E. (1972) Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology, 11:645-663.
5. Graybiel, A.M. (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci., 13:244-253.
6. Herkenham, M., Lynn, A.B., de Costa, B.R., and Richfield, E.K. (1991a) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res., 547:267-274.
7. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R., and Rice, K.C. (1991b) Characterization and localization of cannabinoid receptor in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11:563-583.
8. Herrera-Marschitz, M., and Ungerstedt, U. (1987) The dopamine-γ aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments. Acta Physiol Scand., 129:371-380.
9. Howlett, A.C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol., 35:607-634.
10. 9-tetrahydrocannabinol in mice. Neurosci. Lett., 174: 101-104.
11. Klemm, W.R. (1989) Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol., 32:403-422.
12. Le Moine C., Bloch B. (1995) D1 and D2 dopamine receptor gene expression in the rat stratum: sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J. Comp. Neurol. 355:418-26.
13. Lindvall, O., and Bjorklund, A. (1979) Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway. Br. Res., 172:169-173.
14. Mackie, K., and Hille, B. (1992) Cannabinoid inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci., 89:3825-3829.
15. Mackie, K., Lai, Y., Westenbroek, R., and Mitchell, R. (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J. Neurosci. 15:6552-6561.
16. Mailleux, P., and Vanderhaeghen, J.J. (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience, 48:655-688.
17. 2 receptor binding in the rat brain and pituitary: an in situ hybridization-receptor autoradiographic analysis. J. Neurosci., 10:2587-2600.
18. 1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 46:959-997.
19. 2 dopamine receptor mRNA in the rat brain. Proc. Natl. Acad. Sci., 86:7625-7628.
20. Miller, A., and Walker, J.M. (1995) Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur. J. Pharmacol., 279:179-185.
21. Miller, A., and Walker, J.M. (1996a) Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus. Eur. J. Pharmacol., 304:29-35.
22. Miller, A., and Walker, J.M. (1996b) Micropressure ejection of cannabinoids into the globus pallidus. Soc. Neurosci. Abst. 22:2027.
23. Pertwee, R.G., and Wickens, A.P. (1991) Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids, Neuropharmacology, 30: 237-244.
24. Pucak, M.L., and Grace, A.A. (1994) Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J. Pharmacol. Exp. Ther., 271:1181-1192.
25. Richfield E.K., Herlxenham M. (1994) Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann. Neurol., 36:577-584.
26. Romero, J., de Miguel, R., García-Palomero, E., Fernández-Ruiz, J.J., and Ramos, J.A. (1995) Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res., 694:223-232.
27. B receptors in the motor inhibition produced by agonists of brain cannabinoid receptors. Behav. Pharmacol., 7:299-302.
28. 1 receptor ligand. Life Sci., 15:1249-1257.
29. Santiago, M., and Westerink, B.H.C. (1991) The regulation of dopamine release from nigrostriatal neurons in conscious rats: the role of somatodendritic autoreceptors. Eur. J. Pharmacol., 204:79-85.
30. Sañudo-Peña, M.C., and Walker, J.M. (1997) Role of the subthalamic nucleus on cannabinoid actions in the substantia nigra of the rat. J. Neurophysiol, 77:1635-1638.
31. Sañudo-Peña, M.C., Patrick, S.L., Patrick, R.L., and Walker, J.M. (1996) Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Neurosci. Lett. 206:21-24.
32. Slater P., Lee L.A., Longman D.A., Crossman A.R. (1980) An in vivo method for testing putative GABA-like compounds. S. Pharmacol. Meth., 3:39-49.
33. Souilhac, J., Poncelet, M., Rinaldi-Carmona, M., Le-Fur, G., and Soubrie, P. (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol. Biochem. Behav., 51:3-7.
34. Sukul, N.C., Cherian, L., and Klemm, W.R. (1988) Alpha noradrenergic agonists promote catalepsy in the mouse. Pharmacol. Biochem. Behav., 31:87-91.
35. Vacherri, A., Dall'Olio, R., Gandolfi, O., and Montanaro, N. (1986) Involvement of different dopamine receptors in rat diphasic motility response to apomorphine. Psychopharmacologia, 89:265-268.
36. Wickens, A.P., and Pertwee, R.G. (1993) Delta 9-tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. Eur. J. Pharmacol., 250:205-208.
37. Wilson, C.J. (1993) The generation of natural firing patterns in neostriatal neurons. In: GW Arbuthnott, PC Empson, eds. Chemical Signalling in the Basal Ganglia. Progress Brain Research. Vol. 99. Elsevier, Amsterdam, pp. 277-298.
38. Yamaguchi K., Nabeshima T., Kameyama T. (1986) Role of dopaminergic and GABAergic mechanisms in discrete brain areas in phencyclidine-induced locomotor stimulation and turning behavior. J. Pharmacobiodyn, 9:975-986.
39. a receptor agonists. Neuroscience, 63:427-434.